Received May 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 553J7 | — |
administered an expired dose of Engerix B; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 2-day-old female patient who received HBV (Engerix B) (batch number 553J7, expiry date 28-MAR-2025) for prophylaxis. On 16-MAY-2025, the patient received the 1st dose of Engerix B. On 16-MAY-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: administered an expired dose of Engerix B). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-MAY-2025 The Vaccine Administration Facility was the same as Primary Reporter On 16 May 2025, a nurse administered an expired dose of Engerix B vaccine to a 2 day old patient which led to expired vaccine used. The nurse wanted to know how to proceed in this case.